Canine Parvovirus Monoclonal Antibody
Canine Parvovirus Monoclonal Antibody is the first and only USDA-conditionally approved monoclonal antibody (mAb) treatment that targets canine parvovirus (CPV).
Why choose Canine Parvovirus Monoclonal Antibody?
We anticipate Canine Parvovirus Monoclonal Antibody will help greatly decrease the burden of supportive care for CPV. You may be able to save days of labor and stress associated with managing the symptoms of this potentially deadly disease.
- mAb that targets parvovirus directly
- Single-dose efficacy
- High safety profile
- May help decrease burden of supportive care and may help reduce emotional stress
Important Information
Canine Parvovirus Monoclonal Antibody is indicated for the treatment of canine parvovirus.
Monoclonal Antibody
Intravenous Administration
Delivered in unique packaging designed to keep it at ≤ -15°C or ≤ 5°F and should be stored frozen.
Dosing Information
How Canine Parvovirus Monoclonal Antibody Works
Two components. One powerful product.
Canine Parvovirus Monoclonal Antibody is composed of a dog constant region and a rat variable region.
These two elements work together to neutralize canine parvovirus in vivo by selectively binding and blocking the virus from entering and destroying enterocytes.
Take charge of parvovirus
Now you can treat parvo, not just manage the symptoms. Contact your Elanco sales representative for more information on product availability or call us at 1-888-545-5973.
Canine Parvovirus Monoclonal Antibody Resources
Canine Parvovirus Disease State
Canine Parvovirus Monoclonal Antibody Mode of Action
"Un-Boxing" Video
Parvovirus FAQs
Always read, understand and follow the label and use directions.
